MA30166B1 - Imidazoles substitues et leur utilisation comme pesticides. - Google Patents

Imidazoles substitues et leur utilisation comme pesticides.

Info

Publication number
MA30166B1
MA30166B1 MA31128A MA31128A MA30166B1 MA 30166 B1 MA30166 B1 MA 30166B1 MA 31128 A MA31128 A MA 31128A MA 31128 A MA31128 A MA 31128A MA 30166 B1 MA30166 B1 MA 30166B1
Authority
MA
Morocco
Prior art keywords
pesticides
substituted imidazoles
substituted
parasiticides
solvates
Prior art date
Application number
MA31128A
Other languages
English (en)
Inventor
Nathan Anthony Logan Chubb
Mark Roger Cox
Jerome Sebastien Dauvergne
Richard Andrew Ewin
Christelle Lauret
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MA30166B1 publication Critical patent/MA30166B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Imidazoles substitués et leur utilisation comme pesticides La présente invention concerne un ensemble de dérivés d'imidazole à substituant 2-benzyle alpha-substitués et leurs sels et produits de solvatation pharmaceutiquement acceptables, des compositions comprenant ces composés, des procédés pour leur synthèse, ainsi que leur utilisation comme parasiticides.
MA31128A 2006-01-19 2008-07-18 Imidazoles substitues et leur utilisation comme pesticides. MA30166B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76076506P 2006-01-19 2006-01-19

Publications (1)

Publication Number Publication Date
MA30166B1 true MA30166B1 (fr) 2009-01-02

Family

ID=38038547

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31128A MA30166B1 (fr) 2006-01-19 2008-07-18 Imidazoles substitues et leur utilisation comme pesticides.

Country Status (32)

Country Link
US (4) US7592362B2 (fr)
EP (2) EP1981853B1 (fr)
JP (1) JP4463317B2 (fr)
KR (1) KR101044494B1 (fr)
CN (1) CN101370786B (fr)
AR (1) AR059055A1 (fr)
AT (1) ATE505461T1 (fr)
AU (1) AU2007206698B2 (fr)
BR (1) BRPI0707185B8 (fr)
CA (1) CA2632771C (fr)
CY (1) CY1111473T1 (fr)
DE (1) DE602007013869D1 (fr)
DK (1) DK1981853T3 (fr)
EA (1) EA015738B1 (fr)
ES (1) ES2362935T3 (fr)
HK (1) HK1127919A1 (fr)
IL (1) IL192063A0 (fr)
MA (1) MA30166B1 (fr)
ME (2) ME00044B (fr)
MY (1) MY145812A (fr)
NO (1) NO341141B1 (fr)
NZ (1) NZ569209A (fr)
PL (1) PL1981853T3 (fr)
PT (1) PT1981853E (fr)
RS (1) RS53512B1 (fr)
SI (1) SI1981853T1 (fr)
TN (1) TNSN08306A1 (fr)
TW (1) TWI337998B (fr)
UA (1) UA93696C2 (fr)
UY (1) UY30096A1 (fr)
WO (1) WO2007083207A1 (fr)
ZA (1) ZA200805565B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69943133D1 (de) 1998-11-02 2011-02-24 Dow Global Technologies Inc Unter scherwirkung verflüssigbare ethylen/alpha-olefin/dien polymere und ihre herstellung
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
US20100041712A1 (en) * 2008-08-18 2010-02-18 Pfizer Inc. Substituted imidazole combinations
NZ593676A (en) 2008-12-24 2012-06-29 Daiichi Sankyo Co Ltd Calcium-sensing receptor antagonists
CN102307852B (zh) 2008-12-24 2013-12-18 第一三共株式会社 环状胺化合物
EP2398318B1 (fr) 2009-02-23 2012-12-05 Wyeth LLC Composition ectoparasiticide à parfum amélioré
EP2454226B1 (fr) * 2009-07-16 2017-03-22 Solvay Fluor GmbH Procédé de préparation de fluoroalkyl (fluoro)alkyl carbonates
EP2521545B1 (fr) * 2010-01-07 2019-11-27 Alkermes Pharma Ireland Limited Promédicaments de composés hétéroaromatiques
WO2011092604A2 (fr) 2010-01-29 2011-08-04 Pfizer Inc. Formulations antiparasites topiques
CN102127066B (zh) * 2010-12-10 2013-08-14 邵阳学院 4-(7-甲氧基-2,2-二甲基-2,3-二氢苯并呋喃-5-基)-2-(3,4-二甲苯氨基)噻唑手性晶体
US8685966B2 (en) 2011-04-08 2014-04-01 University Of Kansas GRP94 inhibitors
US9295623B2 (en) * 2011-10-03 2016-03-29 Eq Ag Solutions Methods of preventing the transmission of communicable diseases in livestock
ES2642715T3 (es) 2011-11-17 2017-11-17 Merial, Inc. Composiciones que comprenden un aril pirazol y un imidazol sustituido, procedimientos y utilizaciones de las mismas
CN104168899B (zh) * 2012-01-13 2017-04-05 通用医疗公司 麻醉剂化合物及其相关的使用方法
CN102987824A (zh) * 2012-11-29 2013-03-27 张敏 一种防螨虫被
CN104844459B (zh) * 2014-02-18 2016-08-24 扬州三友合成化工有限公司 一种氯甲基异丙基碳酸酯的制备方法
MX2018005549A (es) * 2015-11-18 2018-11-09 Monsanto Technology Llc Composiciones y metodos insecticidas.
ES2909709T3 (es) 2016-05-12 2022-05-10 Heptares Therapeutics Ltd Inhibidores del receptor 2 activado por proteasa
US10766866B2 (en) 2017-10-30 2020-09-08 University Of North Texas Health Science Center At Fort Worth Deterrents for arthropods and marine organisms
CN115073298A (zh) * 2022-05-31 2022-09-20 湖南华腾制药有限公司 连续流微反应器合成2-甲基-3-三氟甲基苯胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678775A (en) * 1984-05-01 1987-07-07 Nathanson James A Method of controlling pests
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
SU1655293A3 (ru) * 1987-04-21 1991-06-07 Басф Аг (Фирма) Средство дл борьбы с насекомыми
RU2026294C1 (ru) * 1990-06-29 1995-01-09 Сумитомо Кемикал Компани, Лимитед Производные 1-пиридилимидазола и инсектицидная композиция
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
FR2681322B1 (fr) 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
JP3311858B2 (ja) 1994-03-08 2002-08-05 四国化成工業株式会社 銅及び銅合金の表面処理剤
RU2235092C2 (ru) 1997-12-04 2004-08-27 Оллерган Инк. Замещенные производные имидазола, способ введения активного соединения и способ лечения на основе этих соединений
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
TWI283669B (en) 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
WO2001000686A1 (fr) 1999-06-25 2001-01-04 Bayer Aktiengesellschaft Procede de copolymerisation de monomeres polaires et non polaires
AU2001264872A1 (en) 2000-06-05 2001-12-17 Ortho-Mcneil Pharmaceutical, Inc. Method for synthesis of substituted azole libraries
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
DE10304374A1 (de) 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU2004247627A1 (en) 2003-05-16 2004-12-23 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US7812163B2 (en) * 2003-07-16 2010-10-12 Hatchtech Pty Ltd. Methods and compositions for controlling ectoparasites
AU2003903686A0 (en) 2003-07-16 2003-07-31 Hatchtech Pty Ltd Methods and compositions for controlling ectoparasites
CA2539842C (fr) * 2003-09-25 2013-02-12 Dompe S.P.A. Amidines et leurs derives et preparations pharmaceutiques les contenant
EP1584335A3 (fr) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Combinaison de substances actives comprenant un composé carbinol et un opioïde
EP1879455A4 (fr) * 2005-05-03 2011-12-28 Bayer Cropscience Ag Derives aminoalkyles heterocycliques et heteroaryles substitues insecticides
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
BRPI0707315A2 (pt) * 2006-01-27 2011-05-03 Hoffmann La Roche uso de 2-imidazol substituìdo de derivados de imidazolina

Also Published As

Publication number Publication date
US7544706B2 (en) 2009-06-09
CN101370786B (zh) 2012-01-11
TW200738644A (en) 2007-10-16
CY1111473T1 (el) 2015-08-05
BRPI0707185A2 (pt) 2011-04-26
US20080119536A1 (en) 2008-05-22
EP2423199A1 (fr) 2012-02-29
TWI337998B (en) 2011-03-01
IL192063A0 (en) 2008-12-29
ME00044B (me) 2010-06-10
UY30096A1 (es) 2007-08-31
DK1981853T3 (da) 2011-06-20
WO2007083207A1 (fr) 2007-07-26
CA2632771A1 (fr) 2007-07-26
EA015738B1 (ru) 2011-10-31
UA93696C2 (ru) 2011-03-10
ZA200805565B (en) 2009-12-30
US7825149B2 (en) 2010-11-02
US20070167506A1 (en) 2007-07-19
US20090312326A1 (en) 2009-12-17
SI1981853T1 (sl) 2011-08-31
HK1127919A1 (en) 2009-10-09
US7547718B2 (en) 2009-06-16
DE602007013869D1 (de) 2011-05-26
AU2007206698B2 (en) 2011-11-03
CA2632771C (fr) 2011-03-22
JP4463317B2 (ja) 2010-05-19
RS20080304A (en) 2009-05-06
AU2007206698A1 (en) 2007-07-26
BRPI0707185B8 (pt) 2021-05-25
NO20083404L (no) 2008-08-04
TNSN08306A1 (fr) 2009-12-29
EA200870079A1 (ru) 2009-02-27
PT1981853E (pt) 2011-06-27
MEP4208A (en) 2010-06-10
EP1981853A1 (fr) 2008-10-22
KR101044494B1 (ko) 2011-06-27
ES2362935T3 (es) 2011-07-15
AR059055A1 (es) 2008-03-12
BRPI0707185B1 (pt) 2020-03-17
NO341141B1 (no) 2017-08-28
CN101370786A (zh) 2009-02-18
MY145812A (en) 2012-04-30
PL1981853T3 (pl) 2011-08-31
EP1981853B1 (fr) 2011-04-13
KR20080085046A (ko) 2008-09-22
ATE505461T1 (de) 2011-04-15
JP2009528979A (ja) 2009-08-13
US7592362B2 (en) 2009-09-22
RS53512B1 (en) 2015-02-27
NZ569209A (en) 2010-09-30
US20080125473A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
MA30166B1 (fr) Imidazoles substitues et leur utilisation comme pesticides.
MA29549B1 (fr) Arylpyrazoles substitues destines a etre utilises contre des parasites
MA32104B1 (fr) Dérivés d'oxime en tant qu'inhibiteurs de hsp90
MA30988B1 (fr) Composes destines a inhiber la progression mitotique
MA30883B1 (fr) Nouveaux derives de 1,1 - dioxyde de 1.4 - benzothiepine substitues par des radicaux benzyle, leur procede de preparation, les produits pharmaceutiques comprenant ces composes et leur utilisation
MA30781B1 (fr) Inhibiteur de kinase
TNSN07275A1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
MA29550B1 (fr) Derives de n- (pyridine-2-yl) - sulfonamide
MA31655B1 (fr) Pyrimidines cyclopenta [d] hydroxylés et méthoxylés utilisés en tant qu'inhibiteurs de la protéine kinase akt.
MA31593B1 (fr) Derives de 2-aza-bicyclo[3.3.0]octane
MA29791B1 (fr) Composes therapeutiques.
MA30686B1 (fr) Inhibiteurs de la 11-beta-hydroxysteroide deshydrogenase.
MA30952B1 (fr) Cyclopenta [d] pyrimidines utiles en tant qu'inhibiteurs de la proteine kinase akt
MA31419B1 (fr) Derives de pyridine
MA28269A1 (fr) Arylpyrazoles substitués servant d'agents parasiticides
MA33240B1 (fr) Inhibiteurs de bêta-sécrétase
MA29685B1 (fr) Composes spiroheterocycliques et leurs utilisations en tant qu'agents therapeutiques
MA31087B1 (fr) Derives d'amide et d'ester d'indazolyle pour traiter des troubles medies par le recepteur de glucocorticoïde.
MA31763B1 (fr) Inhibiteurs de kinase de type polo
MA30959B1 (fr) Composes de pyrazole et de triazole substitues comme inhibiteurs de ksp
MA30609B1 (fr) Imidazolidine-2,4-diones arylaminoaryl-alkyl-substituees, leur procede de synthese, les medicaments comprenant ces composes, et leurs applications.
MA30604B1 (fr) Agonistes de ep2
MA30042B1 (fr) Composes calcilytiques
MA33384B1 (fr) Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
TNSN06370A1 (fr) Derives de pyrimidine pour le traitement d'une croissance cellulaire anormale